Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000551227 | SCV000641627 | benign | Tuberous sclerosis 1 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001578209 | SCV001805754 | likely benign | not provided | 2020-06-08 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Genome- |
RCV000551227 | SCV002040336 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256369 | SCV002531432 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-05-30 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002256369 | SCV002609715 | likely benign | Hereditary cancer-predisposing syndrome | 2022-11-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003999218 | SCV004826340 | uncertain significance | Tuberous sclerosis syndrome | 2023-06-28 | criteria provided, single submitter | clinical testing |